Brent Egan to Hypertension
This is a "connection" page, showing publications Brent Egan has written about Hypertension.
Connection Strength
26.903
-
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions. Blood Press. 2022 12; 31(1):164-168.
Score: 0.433
-
Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Netw Open. 2022 12 01; 5(12):e2247787.
Score: 0.433
-
Hypertension Control Among US Adults, 2009 to 2012 Through 2017 to 2020, and the Impact of COVID-19. Hypertension. 2022 09; 79(9):1981-1983.
Score: 0.424
-
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
Score: 0.403
-
Editorial commentary: Racial and Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018. Hypertension. 2021 12; 78(6):1727-1729.
Score: 0.403
-
Baseline Heart Rate Predicts the Blood Pressure Response to Renal Denervation in Untreated Hypertension. J Am Coll Cardiol. 2021 09 07; 78(10):1039-1041.
Score: 0.398
-
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups. Hypertension. 2021 09; 78(3):578-587.
Score: 0.391
-
Editorial commentary on 'Country of birth and mortality risk in hypertension with and without diabetes: the Swedish Primary Care Cardiovascular Database'. J Hypertens. 2021 06 01; 39(6):1104-1106.
Score: 0.390
-
Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database. Hypertension. 2020 08; 76(2):330-332.
Score: 0.367
-
Hypertension in military veterans is associated with combat exposure and combat injury. J Hypertens. 2020 07; 38(7):1255-1256.
Score: 0.366
-
Optimal Systolic Blood Pressure Target in Resistant Hypertension. Am J Med. 2019 07; 132(7):e623.
Score: 0.342
-
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019 06; 37(6):1148-1153.
Score: 0.340
-
Adherence in Hypertension. Circ Res. 2019 03 29; 124(7):1124-1140.
Score: 0.336
-
Implementation of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Hypertension. 2019 02; 73(2):288-290.
Score: 0.332
-
Prognostic value of blood pressure control delay in newly diagnosed hypertensive patients. J Hypertens. 2019 02; 37(2):290-291.
Score: 0.332
-
Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension. 2018 12; 72(6):1320-1327.
Score: 0.328
-
Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018 11; 72(5):1090-1092.
Score: 0.326
-
Insights on ?-blockers for the treatment of hypertension: A survey of health care practitioners. J Clin Hypertens (Greenwich). 2018 10; 20(10):1464-1472.
Score: 0.325
-
Defining Hypertension by Blood Pressure 130/80 mm Hg Leads to an Impressive Burden of Hypertension in Young and Middle-Aged Black Adults: Follow-Up in the CARDIA Study. J Am Heart Assoc. 2018 07 14; 7(14).
Score: 0.320
-
Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States. J Clin Hypertens (Greenwich). 2018 06; 20(6):991-1000.
Score: 0.316
-
Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87.
Score: 0.308
-
Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284.
Score: 0.297
-
Physical Activity and Hypertension: Knowing Is Not Enough; We Must Apply. Willing Is Not Enough; We Must Do-von Goethe. Hypertension. 2017 03; 69(3):404-406.
Score: 0.289
-
Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2017 Mar; 19(3):241-249.
Score: 0.284
-
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23.
Score: 0.277
-
Aldosterone Antagonists or Renin-Guided Therapy for Treatment-Resistant Hypertension: A Comparative Effectiveness Pilot Study in Primary Care. Am J Hypertens. 2016 08; 29(8):976-83.
Score: 0.274
-
Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24.
Score: 0.270
-
Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry. J Clin Hypertens (Greenwich). 2016 07; 18(7):663-71.
Score: 0.266
-
Treatment Resistant Hypertension. Ethn Dis. 2015 Nov 05; 25(4):495-8.
Score: 0.265
-
Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9.
Score: 0.254
-
Effectiveness of a tailored behavioral intervention to improve hypertension control. Hypertension. 2015 Feb; 65(2):273-5.
Score: 0.248
-
Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9.
Score: 0.247
-
The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
Score: 0.245
-
Opportunities for multidisciplinary ASH clinical hypertension specialists in an era of population health and accountable care: ASH leadership message. J Am Soc Hypertens. 2014 Jul; 8(7):451-6.
Score: 0.242
-
Diabetes and age-related demographic differences in risk factor control. J Am Soc Hypertens. 2014 Jun; 8(6):394-404.
Score: 0.239
-
Role of aldosterone blockade in resistant hypertension. Semin Nephrol. 2014 May; 34(3):273-84.
Score: 0.239
-
Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
Score: 0.238
-
Formation of community-based hypertension practice networks: success, obstacles, and lessons learned. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):393-7.
Score: 0.237
-
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8.
Score: 0.236
-
Prediction of incident hypertension. Health implications of data mining in the 'Big Data' era. J Hypertens. 2013 Nov; 31(11):2123-4.
Score: 0.231
-
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7.
Score: 0.227
-
Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988-2010. Circulation. 2013 Jul 02; 128(1):29-41.
Score: 0.226
-
Plasma lipidomic profile signature of hypertension in mexican american families. Hypertension. 2013 Sep; 62(3):453-4.
Score: 0.225
-
Sympathetic activation and endothelial dysfunction as therapeutic targets in obesity-related hypertension. J Hypertens. 2013 Feb; 31(2):259-60.
Score: 0.219
-
Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):95-101.
Score: 0.218
-
Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61.
Score: 0.218
-
Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich). 2012 Nov; 14(11):751-9.
Score: 0.215
-
Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension. 2012 Oct; 60(4):891-3.
Score: 0.213
-
Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31.
Score: 0.208
-
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011 Oct; 58(4):579-87.
Score: 0.199
-
Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Hypertension. 2011 Oct; 58(4):542-3.
Score: 0.198
-
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
Score: 0.198
-
Impacting population cardiovascular health through a community-based practice network: update on an ASH-supported collaborative. J Clin Hypertens (Greenwich). 2011 Aug; 13(8):543-50.
Score: 0.197
-
Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7.
Score: 0.196
-
Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: connecting the dots clarifies the picture. Hypertension. 2010 Dec; 56(6):1040-1.
Score: 0.188
-
Prevalence and management of hypertension in the inpatient setting: a systematic review. J Hosp Med. 2011 Sep; 6(7):417-22.
Score: 0.184
-
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50.
Score: 0.182
-
Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension. 2010 Jun; 55(6):1289-95.
Score: 0.181
-
Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52.
Score: 0.180
-
DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010 Apr; 24(4):237-46.
Score: 0.172
-
Pleiotropic benefits of moderate salt reduction. Hypertension. 2009 Sep; 54(3):447-8.
Score: 0.172
-
Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans. J Hum Hypertens. 2009 Dec; 23(12):826-35.
Score: 0.169
-
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801.
Score: 0.168
-
Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle. Hypertension. 2009 Apr; 53(4):598-9.
Score: 0.167
-
Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008 Oct; 10(5):359-66.
Score: 0.162
-
Dietary management in the prevention and treatment of hypertension: does it work? J Clin Hypertens (Greenwich). 2008 Aug; 10(8):632-9.
Score: 0.160
-
Prehypertension: should we be treating with pharmacologic therapy? Ther Adv Cardiovasc Dis. 2008 Aug; 2(4):305-14.
Score: 0.160
-
Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens (Greenwich). 2007 Oct; 9(10):783-9.
Score: 0.151
-
Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep. 2007 Aug; 9(4):314-9.
Score: 0.150
-
From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5.
Score: 0.145
-
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86.
Score: 0.143
-
Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension. J Hypertens. 2006 Jul; 24(7):1383-9.
Score: 0.139
-
Sleep and hypertension: burning the candle at both ends really is hazardous to your health. Hypertension. 2006 May; 47(5):816-7.
Score: 0.137
-
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51.
Score: 0.135
-
Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients. J Clin Hypertens (Greenwich). 2006 Jan; 8(1):50-2.
Score: 0.134
-
Ethnic differences in the treatment and control of hypertension in patients with diabetes. J Clin Hypertens (Greenwich). 2005 Aug; 7(8):445-54.
Score: 0.130
-
Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients. Am J Hypertens. 2005 Aug; 18(8):1026-32.
Score: 0.130
-
Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):386-94.
Score: 0.130
-
Cardioprotection: the role of beta-blocker therapy. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):409-16.
Score: 0.130
-
Prehypertension and cardiovascular morbidity. Ann Fam Med. 2005 Jul-Aug; 3(4):294-9.
Score: 0.130
-
Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. Am J Hypertens. 2005 Jul; 18(7):972-9.
Score: 0.130
-
Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005 May 09; 165(9):1041-7.
Score: 0.128
-
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005; 15(1):11-6.
Score: 0.125
-
Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32.
Score: 0.125
-
Prehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004 Dec 15; 94(12):1496-500.
Score: 0.125
-
Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin. 2004 Dec; 20(12):1909-17.
Score: 0.124
-
A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8.
Score: 0.123
-
Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease. Am J Kidney Dis. 2004 Sep; 44(3):446-54.
Score: 0.122
-
Hypertension in the 21st century: the tide is rising; our daze must end. Hypertension. 2004 Oct; 44(4):389.
Score: 0.122
-
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
Score: 0.120
-
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
Score: 0.117
-
An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
Score: 0.117
-
The role of sympathetic activation in cardiovascular disease. Postgrad Med. 2003 Dec; 114(6 Suppl Role):4-10.
Score: 0.116
-
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. Blood Press. 2023 Dec; 32(1):1-3.
Score: 0.116
-
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85.
Score: 0.115
-
Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction? Hypertension. 2003 Oct; 42(4):457-8.
Score: 0.114
-
2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health. J S C Med Assoc. 2003 Jun; 99(6):157-61.
Score: 0.112
-
Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003 Mar 24; 163(6):681-7.
Score: 0.111
-
DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003 Mar; 41(3):422-30.
Score: 0.110
-
Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects. Am J Hypertens. 2003 Jan; 16(1):67-71.
Score: 0.109
-
Hypertension management during the COVID-19 pandemic: what can we learn for the future? Blood Press. 2022 12; 31(1):47-49.
Score: 0.108
-
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy. Blood Press. 2022 12; 31(1):125-128.
Score: 0.108
-
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure. Blood Press. 2022 12; 31(1):207-209.
Score: 0.108
-
Ethnicity and unprovoked hypokalemia in the ARIC Study. Am J Hypertens. 2002 Jul; 15(7 Pt 1):660-1.
Score: 0.105
-
Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018. Am J Hypertens. 2022 Jun 16; 35(6):514-525.
Score: 0.105
-
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens. 2002 Apr; 15(4 Pt 1):372-9.
Score: 0.103
-
Proceedings From a National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention Workshop to Control Hypertension. Am J Hypertens. 2022 03 08; 35(3):232-243.
Score: 0.103
-
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022 01; 79(1):e1-e14.
Score: 0.100
-
The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypertens. 2001 Oct; 14(10):1032-7.
Score: 0.100
-
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2021 11; 78(5):e38-e50.
Score: 0.100
-
Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep. 2001 Apr; 3(2):107-16.
Score: 0.096
-
The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control. J S C Med Assoc. 2001 Feb; 97(2):57-62.
Score: 0.095
-
Acute physical and mental stress resulted in an increase in fatty acids, norepinephrine, and hemodynamic changes in normal individuals: A possible pathophysiological mechanism for hypertension-Pilot study. J Clin Hypertens (Greenwich). 2021 04; 23(4):888-894.
Score: 0.095
-
Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci. 2000 Oct; 320(4):233-9.
Score: 0.093
-
The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci. 1999 Dec; 318(6):365-8.
Score: 0.088
-
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90.
Score: 0.082
-
Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence. Prostaglandins Leukot Essent Fatty Acids. 1997 Jul; 57(1):57-63.
Score: 0.074
-
Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering. Am J Clin Nutr. 1997 02; 65(2 Suppl):671S-677S.
Score: 0.072
-
Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996 Aug; 28(2):228-37.
Score: 0.070
-
Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents. J Clin Hypertens (Greenwich). 2016 09; 18(9):942-8.
Score: 0.068
-
Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996 Mar; 27(3 Pt 2):723-8.
Score: 0.068
-
Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995 Apr; 25(4 Pt 2):774-8.
Score: 0.064
-
Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):235-43.
Score: 0.064
-
Additive effects of obesity and hypertension to limit venous volume. Am J Physiol. 1995 Feb; 268(2 Pt 2):R562-8.
Score: 0.063
-
Is there a role for dietary fish oil in the treatment of hypertension? J Hum Hypertens. 1994 Dec; 8(12):895-905.
Score: 0.062
-
Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
Score: 0.062
-
Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives. J Hypertens. 1994 Sep; 12(9):1061-7.
Score: 0.061
-
Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night. Am J Hypertens. 1994 Jul; 7(7 Pt 1):609-14.
Score: 0.060
-
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
Score: 0.059
-
In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension. J Hypertens. 2014 Feb; 32(2):251-9.
Score: 0.059
-
Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension. 1994 Jan; 23(1 Suppl):I1-7.
Score: 0.058
-
The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo). 2013 Dec; 68(12):1495-501.
Score: 0.058
-
Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone. J Hypertens. 1993 Oct; 11(10):1113-20.
Score: 0.057
-
Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension. 1993 Oct; 22(4):584-90.
Score: 0.057
-
Blood pressure reclassification in adolescents based on repeat clinic blood pressure measurements. J Clin Hypertens (Greenwich). 2013 Oct; 15(10):717-22.
Score: 0.057
-
Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol. 1993 Jul 01; 72(1):53-7.
Score: 0.056
-
Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure. Am Heart J. 1993 Jun; 125(6):1698-703.
Score: 0.056
-
Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):397-403.
Score: 0.056
-
Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):404-12.
Score: 0.055
-
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol. 2012 Oct 02; 60(14):1271-7.
Score: 0.053
-
Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor? Am J Hypertens. 1992 Sep; 5(9):665-6.
Score: 0.053
-
Adaptive changes in cerebral blood vessels during chronic hypertension. J Hypertens. 1992 Apr; 10(4):399-400.
Score: 0.052
-
Training providers in hypertension guidelines: cost-effectiveness evaluation of a continuing medical education program in South Carolina. Am Heart J. 2011 Oct; 162(4):786-793.e1.
Score: 0.050
-
Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes. 1991 Sep; 15 Suppl 2:133-9.
Score: 0.050
-
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
Score: 0.049
-
Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21.
Score: 0.049
-
Measuring the impact of a continuing medical education program on patient blood pressure. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):517-22.
Score: 0.048
-
Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr. 1991; 69 Suppl 25:45-50.
Score: 0.047
-
Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011; 21(2):129-34.
Score: 0.047
-
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
Score: 0.047
-
Attitudes and practices of resident physicians regarding hypertension in the inpatient setting. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):698-705.
Score: 0.046
-
Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. J Hypertens. 2010 Aug; 28(8):1761-9.
Score: 0.046
-
Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):32-41.
Score: 0.044
-
Neurogenic mechanisms initiating essential hypertension. Am J Hypertens. 1989 Dec; 2(12 Pt 2):357S-362S.
Score: 0.044
-
Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension. Am J Cardiol. 1989 Oct 01; 64(12):752-5.
Score: 0.043
-
The importance of hemodynamic considerations in essential hypertension. Am Heart J. 1988 Aug; 116(2 Pt 2):594-9.
Score: 0.040
-
Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans. Hypertension. 1988 Aug; 12(2):199-203.
Score: 0.040
-
Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension. Am J Hypertens. 1988 Jul; 1(3 Pt 3):324S-330S.
Score: 0.040
-
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY). J Clin Hypertens (Greenwich). 2008 Jun; 10(6):436-42.
Score: 0.040
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
Score: 0.039
-
Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens. 1988 Jan; 6(1):41-8.
Score: 0.039
-
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987 Sep; 80(3):812-7.
Score: 0.038
-
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6.
Score: 0.036
-
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? Am J Cardiol. 2006 Oct 15; 98(8):1122.
Score: 0.035
-
The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):257-60.
Score: 0.034
-
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
Score: 0.034
-
Management of the patient with borderline hypertension. J Cardiovasc Pharmacol. 1986; 8 Suppl 5:S103-7.
Score: 0.034
-
Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. J Clin Hypertens (Greenwich). 2005 Dec; 7(12):705-11; quiz 712-3.
Score: 0.033
-
Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens. 2005 Nov; 23(11):2027-31.
Score: 0.033
-
Nutritional and lifestyle approaches to the prevention and management of hypertension. Compr Ther. 1985 Aug; 11(8):15-20.
Score: 0.033
-
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens. 2005 Jul; 18(7):980-5.
Score: 0.032
-
Fiber and C-reactive protein in diabetes, hypertension, and obesity. Diabetes Care. 2005 Jun; 28(6):1487-9.
Score: 0.032
-
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci. 2005 Jun; 329(6):276-91.
Score: 0.032
-
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci. 2005 Jun; 329(6):292-305.
Score: 0.032
-
Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51.
Score: 0.032
-
A free-ranging roundtable discussion on hypertension. J Hum Hypertens. 2005 Apr; 19(4):259-66.
Score: 0.032
-
Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive. Clin Exp Hypertens A. 1985; 7(2-3):243-55.
Score: 0.031
-
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens. 2005 Jan; 18(1):3-12.
Score: 0.031
-
Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):562-8.
Score: 0.031
-
Trial of preventing hypertension: design and 2-year progress report. Hypertension. 2004 Aug; 44(2):146-51.
Score: 0.030
-
Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep. 2003 Jun; 5(3):247-54.
Score: 0.028
-
Low birth weight as a risk factor for hypertension. J Clin Hypertens (Greenwich). 2003 Mar-Apr; 5(2):133-6.
Score: 0.028
-
Borderline hypertension. Prim Care. 1983 Mar; 10(1):99-113.
Score: 0.028
-
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21.
Score: 0.026
-
Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83.
Score: 0.025
-
Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich). 2001 Jan-Feb; 3(1):29-31.
Score: 0.024
-
Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension. Hypertension. 2000 Jul; 36(1):78-82.
Score: 0.023
-
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci. 1999 Dec; 318(6):357-64.
Score: 0.022
-
Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997 Apr; 313(4):195-209.
Score: 0.018
-
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76.
Score: 0.018
-
Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
Score: 0.017
-
Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995 Nov; 26(5):764-70.
Score: 0.017
-
The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome. J Am Coll Cardiol. 2015 Sep 01; 66(9):1050-67.
Score: 0.016
-
Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension. 1995 Jul; 26(1):186-92.
Score: 0.016
-
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens. 1994 Oct; 7(10 Pt 1):886-93.
Score: 0.015
-
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
Score: 0.013
-
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
Score: 0.011
-
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension. J Hypertens Suppl. 1989 Dec; 7(6):S78-9.
Score: 0.011
-
Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension. Hypertension. 1987 May; 9(5):459-66.
Score: 0.009
-
The heart and the regulation of renin. Circulation. 1987 Jan; 75(1 Pt 2):I130-3.
Score: 0.009
-
Decreased venous distensibility and reduced renin responsiveness in hypertension. Hypertension. 1986 Jun; 8(6 Pt 2):II36-43.
Score: 0.009
-
Anger and anxiety in borderline hypertension. Psychosom Med. 1986 Mar-Apr; 48(3-4):242-8.
Score: 0.008
-
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans. J Cardiovasc Pharmacol. 1985; 7 Suppl 6:S153-8.
Score: 0.008
-
Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension. 1995 Jan; 25(1):30-6.
Score: 0.004